|Day Low/High||3.25 / 3.48|
|52 Wk Low/High||2.53 / 3.96|
Now Available - 12.5 mg/0.4 ml, 17.5 mg/0.4 ml and 22.5 mg/0.4 ml
Stocks with insider trader activity include ATRS, CMT and CTIC
Stocks with insider trader activity include FLML, WLFC and ATRS
The most recent short interest data was recently released by the NASDAQ for the 03/01/2016 settlement date, and Antares Pharma Inc. is one of the most shorted stocks of the Russell 3000, based on 19.06 "days to cover" versus the median component at 5.60.
Collection of 52 Week Safety Data Complete
Antares Pharma (ATRS) stock is decreasing on Tuesday morning after the company reported its 2015 fourth quarter results before today’s opening bell.
Robert Apple Appointed President and Chief Executive Officer
Antares' First ANDA Approval of a Therapeutically Equivalent Complex Generic Product
These under-$10 stocks are within range of triggering breakout trades and moving much higher from current levels.
Last Patient Completes Treatment in the Safety and Efficacy Study QST-13-003
Stocks with insider trader activity include ATRS, SJW and N
Antares Pharma, Inc. (NASDAQ:ATRS) today reported operating and financial results for the second quarter ended June 30, 2015.
Antares Pharma, Inc. (NASDAQ: ATRS) today announced that the first patients have been enrolled in a double-blind, multiple-dose, 26-week safety and pharmacokinetic study of QuickShot ® Testosterone (QS T) administered...
Antares Pharma, Inc. (NASDAQ: ATRS) today announced it will release its second quarter 2015 financial results before the market opens on Monday, August 10, 2015, and host a webcast and conference call shortly thereafter at...
Antares Pharma, Inc. (NASDAQ:ATRS) today announced the appointment of Peter J.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.